High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma.

Name: High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma.
Author: Loosen, Sven H

High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma. — المؤلف: Loosen, Sven H — Carcinogenesis 20200508

المؤلف: Loosen, Sven H
النشر: Carcinogenesis 20200508
الوصف: 947-955 p.
الموضوعات: Adenocarcinoma؛ Adult؛ Aged؛ Aged, 80 and over؛ Biomarkers, Tumor؛ Disease-Free Survival؛ Female؛ Gene Expression Regulation, Neoplastic